Clinical Cognitive Screening vs. Daily Personal Monitoring: What Is the Difference?
Clinical cognitive screening and daily personal monitoring answer different questions. Understanding the distinction helps you use both effectively — and know when each is appropriate.
What each approach does
Clinical cognitive screening — tools like the MoCA, MMSE, SAGE, and more comprehensive neuropsychological batteries — is designed to assess cognitive function at a specific point in time and compare the result against established clinical norms. The question is: does this person's performance today fall within or outside the expected range for their age and education? These assessments are administered by or for clinicians, and their results are interpreted in a clinical context.
Daily personal monitoring — what Keel is built for — is designed to track your cognitive function over time and compare each day's result against your own established baseline. The question is: is this person performing the same as they have been, or has something changed? No single session produces a clinically meaningful result; the value is in the trend across dozens of sessions over weeks and months.
Key differences
Clinical screening and daily monitoring are complementary rather than competing approaches. They answer different questions and operate on different time scales.
- Clinical screening: snapshot at one point in time; daily monitoring: longitudinal trend across time
- Clinical screening: compares you against population norms; daily monitoring: compares you against your own baseline
- Clinical screening: administered periodically (annually, or when concerned); daily monitoring: administered every day
- Clinical screening: results require clinical interpretation; daily monitoring: trend visible to you directly
- Clinical screening: sensitive to test anxiety and educational background; daily monitoring: less affected due to personal comparison
- Clinical screening: best for determining whether significant impairment exists; daily monitoring: best for detecting whether change is occurring
Who each is best for
Clinical screening is better when a doctor needs to determine whether cognitive impairment is present at a clinically significant level. It is also better when a formal diagnosis is needed — for legal, insurance, or care planning purposes — because consumer monitoring tools are not diagnostic instruments. Any formal evaluation process requires clinical-grade tools interpreted by trained clinicians.
Daily personal monitoring is better for the long stretches between clinical visits — which, for most healthy adults, is most of their life. It is also better for individuals who want to know whether their personal cognitive baseline is stable, and for families managing a parent's cognitive health in real time rather than waiting for the next annual appointment.
The case for daily baseline tracking
The fundamental gap that daily monitoring fills is the between-visit period. For most adults, clinical cognitive assessment happens annually at best — more often every few years, or only when a specific concern prompts it. That means there are long stretches of time during which no systematic data is being collected. If something changes during that gap, there is no way to know when the change started or how it progressed.
Daily monitoring fills this gap with data. When your parent's cognition changes between January and September, Keel's daily tracking shows you when in that period the change began, how quickly it progressed, and which domains were affected. That information is invaluable when you arrive at the neurologist's office in October.
Clinical screening and daily monitoring are not in competition — they are different lenses on the same question. The most informed picture of cognitive health comes from using both: periodic clinical assessment for validated clinical benchmarks, and daily monitoring for the longitudinal personal trend that makes those benchmarks interpretable.
Frequently asked questions
Can daily monitoring replace clinical cognitive screening?
No. Keel and similar daily monitoring tools are personal wellness tools, not medical devices or diagnostic instruments. Clinical screening by a trained professional is the appropriate tool for determining whether cognitive impairment exists at a clinically significant level. Daily monitoring complements clinical screening by providing longitudinal context; it does not substitute for clinical judgment.
How often should someone have clinical cognitive screening?
For most healthy adults over 65 without specific risk factors, an annual cognitive check-in with a primary care physician is appropriate. For individuals with risk factors (family history, cardiovascular disease, prior TIA, significant sleep disorders), more frequent monitoring may be warranted — which is where daily home tracking with a tool like Keel becomes particularly valuable between appointments.
My parent just had a normal clinical screening. Should they still use Keel?
A normal screening result is genuinely reassuring. It means no significant cognitive impairment was detected on that day. Daily monitoring from that point forward builds the baseline that makes the next screening result interpretable — you will know whether the next result represents stability or change from a normal baseline, rather than being a standalone data point.
Related resources
Start tracking your cognitive baseline
Four minutes a day. Five short tests. One trend line that builds over weeks and months so you can see where you stand — and separate a bad day from a real change.
Free to start. No account required. Not a diagnostic tool.